Minerva Surgical (UTRS) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock UTRS vs. NMRD, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, HSCSW, BEATW, and LUCYWShould you be buying Minerva Surgical stock or one of its competitors? The main competitors of Minerva Surgical include Nemaura Medical (NMRD), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Heart Test Laboratories (HSCSW), HeartBeam (BEATW), and Innovative Eyewear (LUCYW). These companies are all part of the "medical equipment" industry. Minerva Surgical vs. Its Competitors Nemaura Medical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Heart Test Laboratories HeartBeam Innovative Eyewear Minerva Surgical (NASDAQ:UTRS) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership and earnings. Is UTRS or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Minerva SurgicalN/A N/A N/A Nemaura Medical N/A N/A N/A Does the media prefer UTRS or NMRD? In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Minerva Surgical Neutral Nemaura Medical Neutral Which has more volatility and risk, UTRS or NMRD? Minerva Surgical has a beta of 3.53, meaning that its share price is 253% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.6, meaning that its share price is 40% less volatile than the S&P 500. Which has stronger valuation & earnings, UTRS or NMRD? Nemaura Medical has lower revenue, but higher earnings than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMinerva Surgical$51.69M0.00-$34.11MN/AN/ANemaura Medical$3.02K0.00-$14.14M-$0.39N/A Do insiders & institutionals believe in UTRS or NMRD? 4.4% of Nemaura Medical shares are held by institutional investors. 8.5% of Minerva Surgical shares are held by insiders. Comparatively, 40.4% of Nemaura Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. SummaryNemaura Medical beats Minerva Surgical on 3 of the 5 factors compared between the two stocks. Get Minerva Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UTRS vs. The Competition Export to ExcelMetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$1K$81.81M$5.77B$9.87BDividend YieldN/AN/A6.67%4.51%P/E RatioN/A11.7275.6126.46Price / SalesN/A97.80551.64120.26Price / CashN/A18.4137.1158.92Price / BookN/A9.1011.536.02Net Income-$34.11M-$26.48M$3.29B$266.38M Minerva Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UTRSMinerva SurgicalN/AN/AN/AN/A$1K$51.69M0.00160NMRDNemaura Medical0.9269 of 5 stars$0.00flatN/AN/A$4K$3.02K0.0040MOTSMotus GI0.0867 of 5 starsN/AN/AN/A$1K$319K0.0030VIVEViveve MedicalN/A$0.00flatN/AN/A$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.29-1.1%N/A+30.9%$0.00N/A0.0080Positive NewsGap UpANZUWAnzu Special Acquisition Corp IN/A$0.04-15.3%N/AN/A$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02+18.5%N/A+44.6%$0.00N/A0.00N/AGap UpBBLGWBone BiologicsN/A$10.79-28.1%N/AN/A$0.00N/A0.002Gap DownHSCSWHeart Test LaboratoriesN/A$0.06-0.7%N/AN/A$0.00$4.35K0.0010Positive NewsGap DownBEATWHeartBeamN/A$0.35+21.2%N/A-37.0%$0.00N/A0.005Positive NewsLUCYWInnovative EyewearN/A$0.09+6.4%N/A+184.0%$0.00$1.98M0.009Positive NewsGap Up Related Companies and Tools Related Companies Nemaura Medical Alternatives Motus GI Alternatives Viveve Medical Alternatives Alpha Tau Medical Alternatives Anzu Special Acquisition Corp I Alternatives Aurora Technology Acquisition Alternatives Bone Biologics Alternatives Heart Test Laboratories Alternatives HeartBeam Alternatives Innovative Eyewear Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:UTRS) was last updated on 9/5/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Surgical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Minerva Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
